Miltamato en es it fr

Miltamato Brand names, Miltamato Analogs

Miltamato Brand Names Mixture

  • No information avaliable

Miltamato Chemical_Formula


Miltamato RX_link

No information avaliable

Miltamato fda sheet

Miltamato msds (material safety sheet)

Miltamato Synthesis Reference

No information avaliable

Miltamato Molecular Weight

309.469 g/mol

Miltamato Melting Point

< 25 oC

Miltamato H2O Solubility

Soluble as HCl salt

Miltamato State


Miltamato LogP


Miltamato Dosage Forms

Tablets (oral, 1 mg)

Miltamato Indication

Used for the symptomatic treatment of parkinsonism.

Miltamato Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Miltamato Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Miltamato side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Miltamato Patient Information

Miltamato Organisms Affected

Humans and other mammals